Improving Early Intervention in Hearing Impaired Children Using Functional Near-Infrared Spectroscopy (fNIRS)

Sponsor
The Bionics Institute of Australia (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05847426
Collaborator
(none)
40
1
2
59.9
0.7

Study Details

Study Description

Brief Summary

The goal of this clinical trial is to find out whether hearing test results using functional near-infrared spectroscopy (fNIRS) will help to fast-track early intervention for infants born with a hearing loss. fNIRS is a method of imaging brain activity using light. The main questions are:

  1. Can audiologists make more confident decisions about the optimal interventions at different critical points in the hearing care pathway when they are given additional fNIRS information compared to when they have standard audiology test results alone?

  2. Is the experience of their infant having an fNIRS test acceptable and comfortable for the parents or care givers?

Condition or Disease Intervention/Treatment Phase
  • Other: Provision of standard audiological + fNIRS test results
  • Other: Provision of standard audiological test results only
N/A

Detailed Description

Universal newborn hearing screening (UNHS) has reduced the age of diagnosis of permanent childhood hearing loss from several years down to several weeks. While this is highly desirable, the early diagnosis raises challenges for the audiologists who manage these infants. The challenges are due to a lack of relevant audiological information, particularly about an infant's ability to discriminate between different speech sounds, and, for infants with Auditory Neuropathy, their degree of hearing impairment, which is required to make key management decisions. The missing information causes intervention delays at several time-critical points along the standard hearing care pathway that could seriously affect speech and language development for the infant, with life-long social, educational and employment consequences. The goal of this trial is to assess whether the addition of audiological information provided by fNIRS assessments can address these challenges for audiologists who care for infants with different types of hearing loss and at the different critical decision points in the care pathway.

A pool of at least 40 experienced audiologists will be recruited to participate in the study. In addition, infants with different types and degree of hearing loss, and at the different critical points in their care pathway will be recruited to provide fNIRS test results. For each infant, a group of ten paediatric audiologists will be randomly selected from the large pool and will be provided with anonymised audiological test results. Each audiologist will receive the current test results of the infant twice, once with, and once without the additional fNIRS test results, with 2 months between. Half (5 randomly selected) will receive the standard plus additional fNIRS test results before the standard-alone results and the other half in reverse order. The audiologists will be asked, via a questionnaire, to make clinical decisions relevant to the infant's point in the hearing care pathway and to rate their confidence in their decisions on a sliding scale.

Infants will be recruited for fNIRS tests at each of four points in the care pathway (after diagnosis, after first hearing aid provision, when optimal hearing aid program is established, and after cochlear implantation. The critical management decisions at these four points are, respectively: Is a hearing aid needed?; Is the hearing aid optimally programmed for the infant?; Would the infant be better off with a cochlear implant instead of their hearing aid?; and Is the cochlear implant programmed optimally for the infant?

Parents/guardians will also be surveyed about their experience with the fNIRS test.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
The intervention (provision of additional fNIRS information) will be applied to audiologists in a cross-over design, wherein each audiologist will receive the anonymized current audiological information about a particular infant twice: once with, and once without the additional fNIRS information. Each time, the audiologist will answer questions about key management decisions via a questionnaire and rate their confidence in their decision using a sliding scale. The change in confidence (difference between the two sliding scale answers for the audiologist) when having access to additional fNIRS information will be the raw data analysed. To test the main hypothesis (that including fNIRS information increases confidence in making management decisions) separately for different hearing loss category groups and different points in the care pathway, 232 infants will be recruited to undergo fNIRS testing, divided into subgroups each with target numbers based on power calculation.The intervention (provision of additional fNIRS information) will be applied to audiologists in a cross-over design, wherein each audiologist will receive the anonymized current audiological information about a particular infant twice: once with, and once without the additional fNIRS information. Each time, the audiologist will answer questions about key management decisions via a questionnaire and rate their confidence in their decision using a sliding scale. The change in confidence (difference between the two sliding scale answers for the audiologist) when having access to additional fNIRS information will be the raw data analysed. To test the main hypothesis (that including fNIRS information increases confidence in making management decisions) separately for different hearing loss category groups and different points in the care pathway, 232 infants will be recruited to undergo fNIRS testing, divided into subgroups each with target numbers based on power calculation.
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Improving Early Intervention in Hearing Impaired Children Using Functional Near-Infrared Spectroscopy (fNIRS)
Anticipated Study Start Date :
May 1, 2023
Anticipated Primary Completion Date :
Apr 28, 2028
Anticipated Study Completion Date :
Apr 28, 2028

Arms and Interventions

Arm Intervention/Treatment
Experimental: Provision of standard audiological + fNIRS test results

The treatment arm involves the provision of additional fNIRS sound detection and speech discrimination test results to the audiologists, in addition to standard audiology information. Standard information includes: At diagnosis: unaided Auditory Brainstem Response results; After initial hearing aid provision: as a) above plus aided Cortical Evoked Potentials; After hearing aid program is adjusted to satisfaction: as b) above plus parent observational report, PEACH (2); After initial cochlear implant programming: behavioural observations.

Other: Provision of standard audiological + fNIRS test results
Infants with hearing loss will be tested using functional near-infrared spectroscopy (fNIRS) and a patented analysis algorithm to measure sound detection and discrimination. Their standard audiological test results will also be collected from their audiology service provider/s. Both sets of test results will be given to the participating audiologists in the experimental arm.

Active Comparator: Provision of standard audiological test results only

The standard audiology information available to the audiologists includes: At diagnosis: unaided Auditory Brainstem Response results; After initial hearing aid provision: as a) above plus aided Cortical Evoked Potentials; After hearing aid program is adjusted to satisfaction: as b) above plus parent observational report, PEACH (2); After initial cochlear implant programming: behavioural observations.

Other: Provision of standard audiological test results only
The provision of test results to the audiologist will be the same as in the experimental arm, but without the fNIRS test results included.

Outcome Measures

Primary Outcome Measures

  1. Change in confidence of audiological clinical management decisions when fNIRS hearing test results are included with standard audiological information compared to when using standard information alone [Between each infant's completed fNIRS testing session and 2 months after]

    The questionnaire responses that the participating audiologists provide will measure their confidence in making the appropriate next decision for the infant using a sliding scale (0 (no confidence) to 100 (high confidence)). The data from the sliding scale responses for the same audiologist/infant will be subtracted (confidence with fNIRS minus confidence without fNIRS) to obtain the raw data for analysis.

Secondary Outcome Measures

  1. Parental/Guardian perception of acceptability of fNIRS test process and usefulness of fNIRS test results [Within 2 weeks after their child's fNIRS testing session]

    The results of a parent questionnaire developed by the Advisory Committee (which includes parent members) will be qualitatively evaluated to determine if the fNIRS test process was acceptable, and the test results were perceived as useful. The results will also indicate whether there are aspects of the test process that could be improved in future to make it more acceptable to parents.

Eligibility Criteria

Criteria

Ages Eligible for Study:
24 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes

The above eligibility applies to the participating audiologists who are in the experimental and control arms of the study

Audiologist Inclusion Criteria:
  • Is a qualified audiologist who meets the criteria for membership of Audiology Australia.

  • Has at least 1 year of experience in paediatric diagnostic, hearing aid or cochlear implant audiology service provision in Australia.

  • Provides a signed and dated informed consent form.

Audiologist Exclusion criteria (only for a specific infant test result):
  • Is the managing audiologist for the infant who's results are being provided.

Infants are also recruited into the study to have an fNIRS assessment performed. They do not participate further after the fNIRS test.

Infant Inclusion criteria:
  • Between the ages of 1 and 24 months at the time of fNIRS testing.

  • Has permanent hearing loss in one or both ears as determined by audiological diagnostic testing.

  • Has a legally acceptable representative capable of understanding the informed consent document and providing consent on the participant's behalf.

Infant Exclusion Criteria:
  • There are no exclusion criteria other than not meeting the inclusion criteria.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Bionics Institute East Melbourne Victoria Australia 3002

Sponsors and Collaborators

  • The Bionics Institute of Australia

Investigators

  • Principal Investigator: Professor Colette McKay, Bionics Institute

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Colette McKay, Leader, Translational Hearing Research and Principal Scientist, The Bionics Institute of Australia
ClinicalTrials.gov Identifier:
NCT05847426
Other Study ID Numbers:
  • 90457
First Posted:
May 6, 2023
Last Update Posted:
May 6, 2023
Last Verified:
Apr 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Colette McKay, Leader, Translational Hearing Research and Principal Scientist, The Bionics Institute of Australia
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 6, 2023